Disease: Progressive multifocal leukoencephalopathy
- (18)F-THK5351 Positron Emission Tomography Clearly Depicted Progressive Multifocal Leukoencephalopathy After Mantle Cell Lymphoma Treatment
- <sup>18</sup>F-THK5351 Positron Emission Tomography Clearly Depicted Progressive Multifocal Leukoencephalopathy After Mantle Cell Lymphoma Treatment
- "Shrimp Sign" in Progressive Multifocal Leukoencephalopathy
- A pharmacovigilance study on antibody-drug conjugate (ADC)-related neurotoxicity based on the FDA adverse event reporting system (FAERS)
- A Proposed Approach to Screening and Surveillance Labs for Patients With Multiple Sclerosis on Anti-CD20 Therapy
- Acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome: prevalence, main characteristics, and outcomes in a Brazilian center
- Adult Cerebral Malaria: Acute and Subacute Imaging Findings, Long-term Clinical Consequences
- An atypical case of progressive multifocal leukoencephalopathy in a patient with high grade B-cell lymphoma causing diagnostic delay
- Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab
- Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology
- Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials
- Capecitabine-Related Fourth Nerve Palsy: A Case Report
- Case report: JC polyomavirus nephropathy in simultaneous heart-kidney transplantation: the role of viral-specific <em>in situ</em> hybridization staining
- Causes of hospitalization and predictors of in-hospital mortality among people living with HIV in Sicily-Italy between 2010 and 2021
- Cerebellar progressive multifocal leucoencephalopathy identified by the shrimp sign
- Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome
- Characterization of the brain virome in human immunodeficiency virus infection and substance use disorder
- Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design
- Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles
- Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma
- Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis
- Differentiation of highly pathogenic strains of human JC polyomavirus in neurological patients by next generation sequencing
- Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis
- Epidemiology of progressive multifocal leukoencephalopathy in Japan and effectiveness of mefloquine: A retrospective analysis of a nationwide inpatient database
- Exploring JC polyomavirus sequences and human gene expression in brain tissue of patients with progressive multifocal leukoencephalopathy
- Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
- Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
- Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient
- Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies
- Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod
- Hemorrhagic cystitis induced by JC polyomavirus infection following COVID-19: a case report
- High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection
- HIV-Associated Progressive Multifocal Leukoencephalopathy: A Case Study
- Human neurotropic polyomavirus, JC virus, late coding region encodes a novel nuclear protein, ORF4, which targets the promyelocytic leukemia nuclear bodies (PML-NBs) and modulates their reorganization
- Hydroxychloroquine can be resumed with close monitoring after retinopathy has developed, without major visual loss: Case Report
- Idiopathic CD4+ T-lymphocytopaenia with <em>FLT1</em> mutation complicated by progressive multifocal leucoencephalopathy and EBV+ polymorphic lymphoproliferative disorder
- Idiopathic CD4+ T-lymphocytopaenia with FLT1 mutation complicated by progressive multifocal leucoencephalopathy and EBV+ polymorphic lymphoproliferative disorder
- Inflammatory progressive multifocal leukoencephalopathy with human T-cell lymphotropic virus-1 coinfection
- Isolated pontocerebellar leukoencephalopathy in HIV-related PML: focus on the "shrimp sign"
- Lessons learned after 20 years of real-world experience with natalizumab
- Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study
- Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report
- Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy
- Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody
- Misdiagnosed Progressive Multifocal Leukoencephalopathy (PML) in an HIV-Negative Patient With Discoid Lupus: A Case Report
- Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis
- Newly diagnosed AIDS patient with cerebellar JC virus
- No association between HLA -B*57:01 and prevalence and/or outcome of progressive multifocal leukoencephalopathy in a French Nationwide HIV cohort
- No Association Between HLA-B*57:01 and Prevalence and/or Outcome of Progressive Multifocal Leukoencephalopathy in a French Nationwide Human Immunodeficiency Virus Cohort
- Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China
- Polyomavirus Wakes Up and Chooses Neurovirulence
- Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis
- Presumptive Progressive Multifocal Encephalopathy in an Immunocompetent Patient: A Rare Case Report
- Progressive Multifocal Encephalopathy Holmes Tremor Successfully Treated with Bilateral Deep Brain Stimulation
- Progressive Multifocal Leukoencephalopathy
- Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report database
- Progressive multifocal leukoencephalopathy as the presenting feature in a patient with occult low-count monoclonal B-cell lymphocytosis
- Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging
- Progressive multifocal leukoencephalopathy cannot be due to liver cirrhosis alone
- Progressive multifocal leukoencephalopathy in a lung transplant recipient
- Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus, not receiving any immunosuppressant medication
- Progressive multifocal leukoencephalopathy in an HIV patient: A case report and literature review
- Progressive multifocal leukoencephalopathy in children with HIV: still a challenge
- Progressive multifocal leukoencephalopathy in patients with chronic kidney disease
- Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab
- Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
- Progressive multifocal leukoencephalopathy in the background of chlorambucil treated chronic lymphocytic leukemia: a case report from Nepal
- Progressive multifocal leukoencephalopathy in the brain stem
- Progressive Multifocal Leukoencephalopathy Initially Suspected As Brain Relapse From Classical Hodgkin's Lymphoma
- Progressive Multifocal Leukoencephalopathy Presenting as Primary CNS Malignancy in an Immunocompetent Patient
- Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab
- Progressive multifocal leukoencephalopathy triggered by COVID-19 in a previously asymptomatic person living with undiagnosed HIV infection
- Progressive multifocal leukoencephalopathy with a benign prognosis in an immunocompetent patient - A case report
- Progressive multifocal leukoencephalopathy with hypointense halo on MRI
- Progressive multifocal leukoencephalopathy without overt immunosuppression
- Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
- Rates of John Cunningham virus seroconversion greatly reduced in natalizumab-treated patients during COVID-19-related lockdowns
- Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study
- Revisiting JC virus and progressive multifocal leukoencephalopathy
- Ring-Enhancing Progressive Multifocal Leukoencephalopathy Mimicking Glioma in a Presumed Immunocompetent Patient With a History of Multiple Sclerosis: A Case Report and Review of the Literature
- Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis
- Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series
- Sarcoidosis presenting as progressive multifocal leukoencephalopathy in an apparently immunocompetent adult
- Spongiform leukoencephalopathy unveiled in an autopsy of a drug abuser
- Structural vaccinology, molecular simulation and immune simulation approaches to design multi-epitopes vaccine against John Cunningham virus
- Successful epilepsy surgery in two cases with multiple sclerosis
- Surrogate endpoints for progressive multifocal leukoencephalopathy
- Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era
- Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review
- Teaching NeuroImage: Shrimp Sign in Ataxic Cerebellar Progressive Multifocal Leukoencephalopathy
- The 504th case: Multiple lymph node enlargement, renal insufficiency, blindness, and white matter lesions of the brain
- The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
- The Connecting Link: A Case Report of the First Association of COVID-19 and Progressive Multifocal Leukoencephalopathy
- The impact of social distancing measures on anti-JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis
- The Prognosis of Progressive Multifocal Leukoencephalopathy in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment: A Systematic Review
- The shrimp sign in ataxic cerebellar progressive multifocal leukoencephalopathy
- Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine
- Upregulation of the NKG2D ligand ULBP2 by JC polyomavirus infection promotes immune recognition by natural killer cells
- Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations
- Varicella Zoster Associated Vasculopathy and Retinitis with Natalizumab Use in Multiple Sclerosis